“… 10 Additionally, a recent study found that patients who underwent treatment of OSA were found to have normalization of OCT abnormalities, presumably due to correction of their nocturnal hypoxemia. 11 Patients with peripheral nonperfusion and neovascularization should receive targeted retinal photocoagulation and/or vascular endothelial growth factor antagonist intravitreal therapy which is the mainstay of treatment of proliferative retinopathy. Heightened awareness of the potential role of OSA to cause retinal hypoxia may suggest a greater need for OSA screening in patients, especially diabetics, with peripheral retinal neovascularization, as treatment with CPAP may reduce retinal hypoxic burden.…”